fbpx

New clues for predicting rare brain infection linked to MS drug

New clues for predicting rare brain infection linked to MS drugPublished: 05 October 2021 A new study has found that John Cunningham virus mutations may be an early predictor for brain infection in people receiving Tysabri for multiple sclerosis (MS).  Tysabri works by preventing immune cells from entering the brain
Read More

This MS treatment causes frequent skin issues

This MS treatment causes frequent skin issues Published: 28 July 2021 Skin reactions are common in people with multiple sclerosis (MS) who are being treated with oral Mavenclad (cladribine) a new real-world study from Germany has found.  Almost a third (32%) of people studied developed some form of skin reaction
Read More

Molecular target could stop demyelination

Molecular target could stop demyelination Published: 14 September 2020 A study from the University of Edinburgh has discovered a molecular target that can protect nerves from damage in multiple sclerosis (MS) in mice.  Researchers have been working more than a decade to analyse a natural mechanism in the body which
Read More